483 results found

China's National Medical Products Administration (NMPA) released the 2023 Drug Review Annual Report on its official website on February 4, 2024...

Q1、如果保险公司本身不具备或仅具备部分"互联网+医疗"相关经营资质，其可以如何合规地向其客户提供互联网医疗及/或药品销售服务？根据本ࢰ

On September 8, 2024, the Ministry of Commerce, together with the National Health Commission and the National Medical Products Administration (hereinafter referred to as the "Three Departments"), publicly issued the Notice on Carrying Out Pilot Programs to Expand Opening-Up in the Healthcare Sector (hereinafter referred to as the "Notice")...

Multinational companies have been required to obtain pre-approval from, or complete record-filing with, the Human Genetic Resources Administration of China (HGRAC) ...

Medical enterprises face significant challenges in trademark registration, with high rejection rates stemming from four critical issues: lack of inherent distinctiveness, deceptive or exaggerated claims...

The life sciences industry remained a primary focus for Chinese regulators in 2024. Key developments such as China's first draft law regulating the medical device industry, the Medical Device Administration Law (《中华人民共和国医疗器械管理法（草案征求意见稿）》),

近期，部分医药行业动态引发了广泛关注，临床研究合规问题再次成为众多企业重点讨论的话题。

October started with a week of celebrations for the 75th anniversary of People's Republic of China and a new GossIP number!

As one of the world's largest drug consumer and manufacturing markets, China plays a pivotal role in global pharma patent strategies – and changes in the country's IP landscape can have profound commercial implications.

In order to ensure the effective implementation of the newly revised Patent Law, further improve China's patent protection system...

最近、最高人民法院の知的財産権法廷は、上訴人サンド（中国）製薬有限公司（以下、サンド社）と上訴人江蘇豪森薬業集団有限公司（以

フランスヴァレオクリーニングシステム会社（VALEO SYSTEMES D'ESSUYAGE）と厦门卢卡斯自動車部品有限公司などとの「車ワイパー」に係る発明特許侵害紛争

互联网、大数据、人工智能等数字技术的创新应用，正快速改变传统医疗服务模式。而数字医疗除了受到传统医疗的法律规制，其数字化的特

2020年《专利法》第四次修改设置了上市药品的专利链接制度，随着新专利法自2021年6月1日起施行，中国的药品专利链接制度正式得以建立。2022年4月15

In recent years, the amount of patent infringement lawsuits involving pharmaceutical companies has been increasing,...

China's Supreme People's Court has established a groundbreaking precedent in pharmaceutical patent law, ruling that therapeutic effects comparable to drugs approved after a patent's filing date...

最近坊间比较火的一个授权专利，专利号ZL202110172158.7，发明名称"穿山甲冠状病毒xCoV及其应用和药物抗冠状病毒感染的应用"的发明专利，由于该专利涉ࡡ

On March 15, the website of the Central People's Government released State Order No. 777 "Decision of the State Council on Amending and Abolishing Certain Administrative Regulations" ("Decision")...